Find out where you can connect with our team this year

At the American Epilepsy Society Annual Meeting, Neumirna presented two posters highlighting the potential of its RNA-based approach for drug-resistant epilepsy.

A new critical review by the Neumirna Therepeutic team has been published in Epilepsia, the leading journal in epilepsy research and clinical care.